Integrated DNA Technologies Decoded - Explaining Scientific Fundamentals

CORALVILLE, IA (15th August 2011) – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has released the July issue of its quarterly Decoded newsletter. An excellent resource for biological scientists, the content included ranges from interviews with industry leading scientists and technical overviews of their research, to relevant insights into the history of biological techniques and technical tips for improving your research workflow. In this month’s edition, Brendan Owens, one of IDT’s Scientific Applications Specialists, take us on a journey into the history of vitamin B7. Also known as biotin, this protein eventually became one of the most fundamental components of the molecular biologist’s toolkit. During the 1940s, a young scientist named Edmond Emerson Snell chanced upon the high affinity bonding observed between avidin and biotin while investigating vitamin deficiency in young chicks. These days, this strong bond is utilized in a wide range of systems, such as the labeling of oligonucleotides with fluorescent molecules. To find out more and read other interesting articles, download the latest issue of Decoded.

To find out more information on IDT please visit www.idtdna.com.

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT’s primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com

MORE ON THIS TOPIC